Itamar Megiddo

Fellow

Itamar Megiddo is a fellow at CDDEP, where has been part of the team since 2010. His research is interdisciplinary and focuses on modeling to improve decision-making in healthcare policy, utilizing tools and methodologies from mathematical epidemiology, economics, and computer science, among other areas.

Dr. Megiddo’s main body of work integrates disease and economic models for policy impact evaluation. He has developed infectious and non-communicable disease models, including a pneumococcal disease model for the Global Antibiotic Resistance Partnership (GARP) and agent-based models integrating population, healthcare, economic, and disease dynamics for the Disease Control Priorities (DPC-3) project. Currently, Dr. Megiddo is working on valuation of antibiotics for DRIVE-AB, an Innovative Medicines Initiative (IMI) funded project investigating mechanisms to encourage research and development of new antibiotics and to promote their global access and sustainable use. Dr. Megiddo is also interested in using game-theoretic models to study the behavior of individuals and actors facing healthcare decisions, and to study how the actors’ behavior impacts the population.

Dr. Megiddo is a Chancellor’s Fellow, Lecturer (Assistant Professor) at the University of Strathclyde in Glasgow, UK. He received his PhD from the department of Management Science at the University of Strathclyde, and he completed his MA economics and BA honors economics at McGill University in Montreal.

Publications

22 Jun 2016

How can we model the transmission of Streptococcus pneumoniae for public health and policy, capturing the...

11 Nov 2015

Among rural Indian households who currently do not have access to (or those who do not access) neonatal care, what are the health and economic benefits of scaling up access to a package of home-...

4 Dec 2014

What is the cost-effectiveness of policies that expand the use of aspirin, injection streptokinase, beta-blockers, angiotensin-converting enzyme inhibitors, and statins for in India for treatment...

10 Aug 2014

How would increasing immunization coverage and introducing a rotavirus vaccine affect the disease and financial burden of vaccine-preventable illnesses in India?

10 Apr 2014

Objectives: To estimate the epidemiological and financial benefits and the distributional consequences of policy interventions for coronary heart disease (CHD) and secondary...

17 Jun 2013

What determines an Indian household's choice of healthcare provider?